Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study finds genetic variants that increase osteoporosis risk in Asian women

This article was originally published in Clinica

Executive Summary

Variations in genes encoding the interleukin (IL) proteins are associated with an increased risk of fracture in Asian women, according to a study presented by Interleukin Genetics. The trial, involving over 1,200 Korean and Japanese women, found that Korean women who had a single nucleotide polymorphism (SNP) of the IL-10 gene were 70% more likely to have a vertebral fracture. Those with an SNP in the IL1-RN gene had a 50% increased risk. The study also found differences in genetic markers between Asian and Caucasian postmenopausal women. The researchers hope the results could be used to identify high-risk women and guide the treatment of osteoporosis. The findings were reported at the eighth International Symposium on Osteoporosis: Translating Research into Clinical Practice, in Washington, DC, on April 4.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel